Titan Pharmaceuticals
TTNP
#11025
Rank
C$8.69 M
Marketcap
C$6.54
Share price
-3.76%
Change (1 day)
17.29%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -C$3.92 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$6.68 Million, an increase over its 2023 earnings that were of -C$7.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$3.92 Million-41.38%
2024 -C$6.68 Million-15.5%
2023 -C$7.9 Million-45.43%
2022 -C$14.48 Million16.29%
2021 -C$12.45 Million-907.36%
2020 C$1.54 M-106.6%
2019 -C$23.35 Million82.4%
2018 -C$12.8 Million-36.93%
2017 -C$20.3 Million-378.62%
2016 C$7.28 M-145.53%
2015 -C$16 Million369.37%
2014 -C$3.41 Million-125.9%
2013 C$13.16 M-177.74%
2012 -C$16.93 Million13.59%
2011 -C$14.91 Million74.37%
2010 -C$8.55 Million3.61%
2009 -C$8.25 Million
2007 -C$26.15 Million12.08%
2006 -C$23.33 Million-28.65%
2005 -C$32.7 Million-10.03%
2004 -C$36.35 Million-6.08%
2003 -C$38.7 Million-14.76%
2002 -C$45.4 Million32.52%
2001 -C$34.26 Million27.55%
2000 -C$26.86 Million62.5%
1999 -C$16.53 Million4.04%
1998 -C$15.89 Million49.33%
1997 -C$10.64 Million-27.88%
1996 -C$14.76 Million13.04%
1995 -C$13.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.55 B-667,515.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$17.93 B-450,830.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-C$0.27 Billion 6,519.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$0.10 B-2,748.84%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$15.25 Million 283.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.47 Billion 11,515.97%๐Ÿ‡บ๐Ÿ‡ธ USA